Intermittent administration of senolytics retains the potential to reduce the chance of patients producing adverse circumstances, limit off-target results of drugs and prevent growth of drug resistance of senescent cells, which don't divide, a characteristic that sets them aside from cancer cells, as most cancers cells frequently get beneficial mutations https://collinfesdb.blogthisbiz.com/35766064/the-best-side-of-recombinant